A detailed history of California State Teachers Retirement System transactions in Amgen Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 868,507 shares of AMGN stock, worth $236 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
868,507
Previous 871,350 0.33%
Holding current value
$236 Million
Previous $272 Million 2.79%
% of portfolio
0.33%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $879,567 - $959,171
-2,843 Reduced 0.33%
868,507 $280 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $987,677 - $1.2 Million
-3,759 Reduced 0.43%
871,350 $272 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $1.83 Million - $2.21 Million
6,798 Added 0.78%
875,109 $249 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $3.37 Million - $3.8 Million
13,168 Added 1.54%
868,311 $250 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $7.02 Million - $8.71 Million
-32,098 Reduced 3.62%
855,143 $230 Million
Q2 2023

Aug 21, 2023

SELL
$214.27 - $253.37 $3.78 Million - $4.47 Million
-17,644 Reduced 1.95%
887,241 $197 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $2.37 Million - $2.89 Million
-10,494 Reduced 1.15%
904,885 $219 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $2.75 Million - $3.49 Million
11,990 Added 1.33%
915,379 $240 Million
Q3 2022

Nov 18, 2022

SELL
$224.46 - $253.15 $8.2 Million - $9.24 Million
-36,517 Reduced 3.89%
903,389 $204 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $4.27 Million - $4.75 Million
-18,517 Reduced 1.93%
939,906 $229 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $14.7 Million - $16.3 Million
-67,009 Reduced 6.53%
958,423 $232 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $5.26 Million - $6.03 Million
26,472 Added 2.65%
1,025,432 $231 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $6.87 Million - $8.05 Million
-32,365 Reduced 3.14%
998,960 $212 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $26.8 Million - $29.7 Million
-114,593 Reduced 10.0%
1,031,325 $251 Million
Q1 2021

May 18, 2021

SELL
$221.91 - $258.6 $2.05 Million - $2.39 Million
-9,257 Reduced 0.8%
1,145,918 $285 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $125,284 - $149,190
-579 Reduced 0.05%
1,155,175 $266 Million
Q3 2020

Nov 17, 2020

BUY
$234.65 - $260.95 $3.21 Million - $3.57 Million
13,664 Added 1.2%
1,155,754 $294 Million
Q2 2020

Aug 17, 2020

BUY
$197.81 - $242.74 $11.7 Million - $14.4 Million
59,316 Added 5.48%
1,142,090 $269 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $3.74 Million - $4.96 Million
-20,522 Reduced 1.86%
1,082,774 $220 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $15.3 Million - $19.6 Million
80,648 Added 7.89%
1,103,296 $266 Million
Q3 2019

Nov 15, 2019

SELL
$174.11 - $208.62 $831,897 - $996,786
-4,778 Reduced 0.47%
1,022,648 $198 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $18.4 Million - $21.6 Million
-110,362 Reduced 9.7%
1,027,426 $189 Million
Q1 2019

May 09, 2019

SELL
$180.87 - $203.88 $2.31 Million - $2.61 Million
-12,796 Reduced 1.11%
1,137,788 $216 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $1.13 Million - $1.32 Million
6,338 Added 0.55%
1,150,584 $224 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $12,043 - $13,577
-65 Reduced 0.01%
1,144,246 $237 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $23.8 Million - $26.7 Million
-143,238 Reduced 11.12%
1,144,311 $211 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $10.9 Million - $12.8 Million
-64,551 Reduced 4.77%
1,287,549 $220 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $12.3 Million - $13.8 Million
72,974 Added 5.7%
1,352,100 $235 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $214 Million - $244 Million
1,279,126
1,279,126 $238 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.